Posts from Mursalin Pathan

Mursalin Pathan is a life sciences professional specializing in healthcare, pharmaceuticals, biotechnology, and medical devices. Passionate about bridging the gap between complex science and everyday understanding. She creates content that makes complex scientific information clear and accessible, skillfully translating intricate concepts, emerging technologies, and key industry developments into actionable, practical insights. Through her research driven articles and blogs, she empowers readers, professionals, and organizations to stay informed and engage confidently with the rapidly evolving life sciences landscape.
Filter by Posts
 News
 Blogs
Filter by Category
Aerospace and Defense
Automotive & Transportation
Banking, Financial Services, and Insurance
Chemicals & Materials
Consumer Goods
Electronics & Semiconductors
Energy & Power
Food & Beverages
Life Sciences
Manufacturing & Construction
Technology, Media, and Telecommunications

Orthodontic Brackets: The Growing Trend Among Adults

Adults increasingly choose orthodontic treatment to improve both confidence and oral health. As a result, orthodontic brackets have become popular worldwide. Many adults now recognize the importance of straight teeth for professional appearance and long-term...

Publication Date: May 29, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Aspiration Catheter: Enhancing Precision in Clot Removal

Cardiovascular diseases and vascular blockages continue to increase worldwide, creating an urgent need for faster and safer treatment procedures. Therefore, healthcare professionals increasingly rely on advanced interventional technologies to efficiently remove clots. Among these innovations,...

Publication Date: May 27, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

EU Approves PYRUKYND (mitapivat) for Adult Thalassemia Care

The European Commission has approved PYRUKYND (mitapivat) for adults living with alpha- or beta-thalassemia across European Union member states. The decision marks a significant milestone because PYRUKYND becomes the only approved medicine in Europe for...

Publication Date: May 26, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Nuclear Medicine: Transforming Modern Diagnostic Imaging

Modern healthcare continues to evolve rapidly, and nuclear medicine now stands at the forefront of diagnostic innovation. It provides a unique blend of functional imaging and clinical precision, enabling clinicians to detect diseases earlier and...

Publication Date: May 26, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

FDA Approves Datopotamab Deruxtecan-Dlnk for TNBC

The U.S. Food and Drug Administration approved datopotamab deruxtecan-dlnk for adults with unresectable or metastatic triple-negative breast cancer (TNBC). The approval targets patients who are not candidates for PD-1 or PD-L1 inhibitor therapy. Consequently, the...

Publication Date: May 25, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Brain Health Across the Lifespan: Key Factors You Should Know

Brain health plays a crucial role in shaping how individuals think, feel, and function across every stage of life. Moreover, recent scientific evidence shows that brain health does not depend solely on genetics or aging....

Publication Date: May 25, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Regeneron–Parabilis Medicines to Advance Antibody-Helicon Conjugates

Regeneron Pharmaceuticals announced a strategic collaboration with Parabilis Medicines to develop cutting-edge therapies. The agreement centers on antibody-Helicon conjugates, a novel approach designed across multiple therapeutic areas to target intracellular proteins that traditional therapies cannot...

Publication Date: May 19, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Thermoplastic Splints: Modern Support for Faster Healing

Healthcare continues evolving rapidly; therefore, clinicians increasingly adopt advanced solutions that enhance recovery outcomes while improving overall patient comfort. Among these innovations, thermoplastic splints have become an essential tool for managing injuries and supporting rehabilitation...

Publication Date: May 19, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

FDA Approves fam-trastuzumab deruxtecan-nxki in Breast Cancer for HER2 Therapy

The U.S. Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki for two new indications in HER2-positive early-stage breast cancer treatment. Additionally, the decision significantly broadens the role of fam-trastuzumab deruxtecan-nxki in curative-intent care settings across earlier...

Publication Date: May 18, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

Chest Sensor Technology Revolutionizes Respiratory Monitoring

Chest sensor innovation is rapidly reshaping respiratory monitoring, as healthcare providers increasingly adopt wearable technologies to improve patient outcomes and efficiency. A new generation of chest sensor devices, inspired by traditional stethoscopes, is delivering continuous,...

Publication Date: May 18, 2026    |    Author Name: Mursalin Pathan    |    Industry: Life Sciences

 
    News 1 to 10  | Total Count : 230
  • 1
    •  2 3 »  Last
© The News and Media Division of The Insight Partners 2026 | All Rights Reserved | Privacy Policy